Lapatinib Completed Phase 2 Trials for Her2-Positive Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01688609Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer